<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04154449</url>
  </required_header>
  <id_info>
    <org_study_id>164: 2/2019</org_study_id>
    <nct_id>NCT04154449</nct_id>
  </id_info>
  <brief_title>Effect of Intranasal Insulin on Postoperative Cognitive Dysfunction</brief_title>
  <official_title>Effect of Intranasal Insulin on Postoperative Cognitive Dysfunction in Middle Aged Patients Undergoing Non Cadiac Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Minia University</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our study is designed to evaluate the effect of intranasal insulin on postoperative cognitive
      dysfunction.

      Primary outcome:

      1. The occurrence of cognitive dysfunction at approximately 7 days after surgery.

      Secondary outcome:

      1. Incidence of any side effect.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 25, 2019</start_date>
  <completion_date type="Anticipated">December 25, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 25, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cognitive dysfunction</measure>
    <time_frame>7 days</time_frame>
    <description>The occurrence of cognitive dysfunction at approximately 7 days after surgery.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">57</enrollment>
  <condition>Middle Aged Patients</condition>
  <arm_group>
    <arm_group_label>Control group.</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgical group Received intranasal insulin.</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgical group Received placebo.</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intranasal insulin</intervention_name>
    <description>Surgical group Received intranasal insulin, the second group surgical Received placebo and the third group is non surgical do not receive anything.</description>
    <arm_group_label>Surgical group Received intranasal insulin.</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        1. Age 40 - 60 years.

          2. Both gender.

          3. Patients will be scheduled for elective major abdominal, thoracic, orthopedic, open
             gynecological, open urological, spine, otolaryngological surgeries under general
             anesthesia with expected hospital stay &gt;4 days.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 40 - 60 years.

          2. Both gender.

          3. Patients will be scheduled for elective major abdominal, thoracic, orthopedic, open
             gynecological, open urological, spine, otolaryngological surgeries under general
             anesthesia with expected hospital stay &gt;4 days.

        Exclusion Criteria:

          -  1. Drug allergy. 2. Patients with major psychiatric disease. 3. Patients receive major
             tranquillizers and antidepressant. 4. Those undergoing neurosurgery or cardiac
             surgery. 5. Those unable or unwilling to abide by the study procedure 6. Those who
             could not follow procedure or who had poor comprehension of dutch language. 7. Those
             with sever visual and auditory disorder / handicaps.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nourhan Mohamed Anter</last_name>
    <phone>01100418846</phone>
    <phone_ext>01012660236</phone_ext>
    <email>nourhananter1992@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Minia University</name>
      <address>
        <city>Minya</city>
        <zip>61111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nourhan NM Mohamed Anter, Resident</last_name>
      <phone>01100418846</phone>
      <email>nourhananter1992@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Minia university</name>
      <address>
        <city>Minya</city>
        <zip>61111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>September 7, 2019</study_first_submitted>
  <study_first_submitted_qc>November 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2019</study_first_posted>
  <last_update_submitted>November 4, 2019</last_update_submitted>
  <last_update_submitted_qc>November 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Minia University</investigator_affiliation>
    <investigator_full_name>Nourhan mohamed anter</investigator_full_name>
    <investigator_title>Resident of anesthesia and Intensive care</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

